Skip to main navigation Skip to search Skip to main content

Serum 1,25-Dihydroxyvitamin D in Bone Disease

  • Robert Steendijk
  • , Marc K. Drezner
  • , Mark R. Haussler
  • , Charles R. Scriver
  • , Theresa M. Reade
  • , Hector F. Deluca
  • , Alan J. Hamstra

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: In a recent paper1 Scriver et al. stated that in patients with hypophosphatemic bone disease, active rickets is not observed, while serum phosphate is low and the level of 1α,25-dihydroxyvitamin D is normal. On the other hand, in patients with X-linked hypophosphatemia rachitic bone disease is present with similarly low levels of serum phosphate and decreased concentrations of 1α,25-dihydroxyvitamin D. This finding encouraged the authors to believe that a normal level of 1α,25-dihydroxyvitamin D prevents severe bone demineralization or, perhaps better, severe impairment of mineralization. It is possible to agree with this line of thought if the.

Original languageEnglish (US)
Pages (from-to)434-435
Number of pages2
JournalNew England Journal of Medicine
Volume300
Issue number8
DOIs
StatePublished - Feb 22 1979

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Serum 1,25-Dihydroxyvitamin D in Bone Disease'. Together they form a unique fingerprint.

Cite this